摘要
目的:探讨HIV/HCV共感染患者肝损害影响因素。方法:回顾性分析92例HIV/HCV共感染患者,男51例(55.4%),女41例(44.6%)。年龄9~62岁,平均(39.5±9.4)岁。分别采用单因素及Logistic回归方法分析其肝损害影响因素。结果:单因素分析发现肝损害组20例(33.9%)有抗结核治疗史,39例(66.1%)有抗逆转录病毒治疗史,37例(62.7%)CD4+T淋巴细胞计数<200个/mm3;无肝损害组患者4例(12.1%)有抗结核治疗史,13例(39.4%)有抗逆转录病毒治疗史,14例(42.4%)CD4+T淋巴细胞计数<200个/mm3,统计学分析差异有显著性(P值分别等于0.023、0.013、0.031)。Logistic回归分析提示抗结核治疗和抗逆转录病毒治疗是HIV/HCV共感染患者肝损害的危险因素。结论:HIV/HCV共感染患者肝损害的影响因素是多方面的,其中抗结核治疗和抗逆转录病毒治疗是其独立危险因素。
Objective To explore the risk factors for liver injury in patients with HIV and HCV coinfection. Methods 92 HIV/HCV coinfected patients [51 males and 41 females; aged 9-62 years, mean (39.5 ± 9.4)years] were retrospectively reviewed. The risk factors for liver injury were analyzed by single-variant analysis and multivariant analysis. Results In the group with liver injury, 20 patients (33.9%) had a history of antituberculous therapy, 39 (66.1%) had a history of antiretroviral treatment, and 37 (62.7%) had a CD4 count lower than 200/mm^3; while 4 patients (6.8%) had a history of antitubereulous therapy, 13 (22.0%) had a history of antiretroviral treatment, and 14 (22.7%) had a CD4 count lower than 200/mm^3 in the group without liver injury. The differences between the two groups were significant (P = 0.023, 0.013, and 0.031; respectively). Logistic regression analysis revealed that antituberculous therapy or antiretroviral therapy was an independent risk factor for liver injury in HIV/HCV coinfected patients. Conclusions Of the multiple factors associated with liver injury in patients with HIV and HCV coinfection, antitubercoulous or antiretroviral therapy is an independent risk factor.
出处
《实用医学杂志》
CAS
北大核心
2009年第18期3042-3044,共3页
The Journal of Practical Medicine
基金
北京市科委艾滋病重大项目(编号:D0906003040591)
国家高技术研究发展计划项目(编号:2006AA02Z411)
首都医学发展科研基金项目(编号:2005-2033)